| CNY billions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13.6 | 16.6 | 16.6 | 16.3 | 17.2 | 18.7 | +8.8% | |
| Cost of revenue | 3.2 | 3.8 | 4.9 | 5.8 | 6.6 | 3.5 | −47.4% | |
| Gross profit | 10.4 | 12.8 | 11.7 | 10.4 | 10.6 | 15.2 | +43.6% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.5 | 2.6 | 2.6 | 2.4 | 2.2 | 0.0 | −100.0% | |
| Selling & marketing | 1.1 | 2.1 | 2.2 | 1.9 | 1.7 | 0.0 | −100.0% | |
| Operating expenses | 6.6 | 6.1 | 7.2 | 5.6 | 3.1 | 8.9 | +189.5% | |
| Operating income | 3.8 | 6.8 | 4.5 | 4.9 | 7.5 | 6.3 | −16.0% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 2.3 | 2.3 | 3.7 | 5.3 | 6.9 | 8.3 | +21.3% | |
| Other income / expense | 0.3 | 0.2 | 0.3 | 0.4 | 0.4 | 0.8 | +133.5% | |
| Pre-tax income | 4.1 | 7.0 | 4.7 | 5.3 | 7.9 | 7.2 | −9.1% | |
| Income tax | 0.6 | 1.3 | 0.7 | 1.0 | 1.6 | 1.4 | −17.1% | |
| Net income | 3.5 | 5.8 | 4.0 | 4.3 | 6.3 | 5.8 | −7.4% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 22.19 | 37.18 | 26.17 | 26.71 | 42.62 | 87.40 | +105.1% | |
| EPS, diluted (per share) | 21.53 | 35.52 | 25.42 | 26.07 | 41.90 | 85.58 | +104.2% | |
| EBITDA | 8.6 | 9.9 | 8.9 | 8.0 | 8.1 | 7.2 | −10.4% | |
| Depreciation & amortization | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | −9.0% | |
| Weighted average shares (shares) | 149,111,103 | 153,632,800 | 156,294,636 | 160,374,902 | 149,006,000 | 66,624,000 | −55.3% | |
| Weighted average diluted shares (shares) | 153,332,549 | 160,698,876 | 161,009,255 | 164,254,472 | 151,725,000 | 68,043,000 | −55.2% | |
| Gross margin | 76.4% | 77.2% | 70.7% | 64.1% | 61.8% | 81.5% | +19.7 pts | |
| Operating margin | 27.9% | 40.8% | 27.0% | 29.8% | 43.9% | 33.9% | −10.0 pts | |
| Net margin | 25.8% | 34.8% | 24.3% | 26.3% | 36.5% | 31.0% | −5.5 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in CNY; the shares trade in USD.
